Cite
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib.
MLA
Guo, Menglin, et al. “A Real-World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) Events for Niraparib.” Scientific Reports, vol. 12, no. 1, Nov. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41598-022-23726-4.
APA
Guo, M., Shu, Y., Chen, G., Li, J., & Li, F. (2022). A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib. Scientific Reports, 12(1), 1–10. https://doi.org/10.1038/s41598-022-23726-4
Chicago
Guo, Menglin, Yamin Shu, Guosong Chen, Juan Li, and Feie Li. 2022. “A Real-World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) Events for Niraparib.” Scientific Reports 12 (1): 1–10. doi:10.1038/s41598-022-23726-4.